ID   NUCOLL43
AC   CVCL_VN96
DR   CancerTools; 153716
DR   Wikidata; Q98128120
DR   Ximbio; 153716
RX   PubMed=30109783;
CC   Characteristics: Does not express TP53. Very high degree of loss of heterozygosity that affects 85% of the genome.
CC   Doubling time: 45 hours (Note=At 13th passage), 42 hours (Note=At 35th passage) (PubMed=30109783).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=30109783
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 11
ST   D16S539: 10,12
ST   D5S818: 13
ST   D7S820: 11,13
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 7
//
RX   PubMed=30109783; DOI=10.1002/cam4.1724; PMCID=PMC6144150;
RA   Franklin M., Gentles L., Matheson E., Bown N., Cross P., Ralte A.,
RA   Gilkes-Immeson C., Bradbury A., Zanjirband M., Lunec J., Drew Y.,
RA   O'Donnell R.L., Curtin N.J.;
RT   "Characterization and drug sensitivity of a novel human ovarian clear
RT   cell carcinoma cell line genomically and phenotypically similar to the
RT   original tumor.";
RL   Cancer Med. 7:4744-4754(2018).
//